Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances

NCT00353860 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

NIH

Sponsor class

Conditions

Immunosuppression
Leukemia

Interventions

DEVICE: SOLEX 300i Stem Cell Selection

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)